Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3765276013 | Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3765277016 | Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3765276013 | Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3765277016 | Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has precise active ingredient | Naloxone hydrochloride | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength numerator value | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has manufactured dose form | Sublingual tablet (product) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has basis of strength substance (attribute) | Buprenorphine | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has basis of strength substance (attribute) | Naloxone hydrochloride | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Is a | Buprenorphine and naloxone only product in oromucosal dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mcg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Has precise active ingredient | Buprenorphine | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely buprenorphine 2 milligram and naloxone hydrochloride 500 microgram/1 each conventional release sublingual tablet (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets